Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 5
2000 2
2001 1
2003 2
2004 5
2005 7
2006 6
2007 8
2008 3
2009 4
2010 6
2011 7
2012 5
2013 5
2014 5
2015 4
2016 9
2017 7
2018 4
2019 2
2020 8
2021 8
2022 6
2023 8

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Severe asthma: definition, diagnosis and treatment.
Lommatzsch M, Virchow JC. Lommatzsch M, et al. Dtsch Arztebl Int. 2014 Dec 12;111(50):847-55. doi: 10.3238/arztebl.2014.0847. Dtsch Arztebl Int. 2014. PMID: 25585581 Free PMC article. Review.
Disease-modifying anti-asthmatic drugs.
Lommatzsch M, Brusselle GG, Canonica GW, Jackson DJ, Nair P, Buhl R, Virchow JC. Lommatzsch M, et al. Lancet. 2022 Apr 23;399(10335):1664-1668. doi: 10.1016/S0140-6736(22)00331-2. Lancet. 2022. PMID: 35461560 Review. No abstract available.
The Treatment of Mild and Moderate Asthma in Adults.
Lommatzsch M, Buhl R, Korn S. Lommatzsch M, et al. Dtsch Arztebl Int. 2020 Jun 19;117(25):434-444. doi: 10.3238/arztebl.2020.0434. Dtsch Arztebl Int. 2020. PMID: 32885783 Free PMC article. Review.
A2BCD: a concise guide for asthma management.
Lommatzsch M, Brusselle GG, Levy ML, Canonica GW, Pavord ID, Schatz M, Virchow JC. Lommatzsch M, et al. Lancet Respir Med. 2023 Jun;11(6):573-576. doi: 10.1016/S2213-2600(22)00490-8. Epub 2023 Jan 27. Lancet Respir Med. 2023. PMID: 36716752 Review.
Asthma-Remission als realistisches Ziel.
Lommatzsch M, Gessner C. Lommatzsch M, et al. MMW Fortschr Med. 2023 Jun;165(11):5. doi: 10.1007/s15006-023-2579-7. MMW Fortschr Med. 2023. PMID: 37258813 German. No abstract available.
Management des Anaphylaxie-Risikos bei Covid-19-Impfung.
Worm M, Ring J, Klimek L, Jakob T, Lange L, Treudler R, Beyer K, Werfel T, Biedermann T, Bircher A, Fischer M, Fuchs T, Heller AR, Hoffmann F, Huttegger I, Kopp MV, Kugler C, Lommatzsch M, Pfaar O, Rietschel E, Ruëff F, Schnadt S, Seifert R, Stöcker B, Vogelberg C, Sitter H, Gieler U, Brockow K. Worm M, et al. Among authors: lommatzsch m. HNO Nachr. 2021;51(1):18-21. doi: 10.1007/s00060-021-7480-3. Epub 2021 Feb 26. HNO Nachr. 2021. PMID: 33619418 Free PMC article. Review. German. No abstract available.
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial.
FitzGerald JM, Bleecker ER, Nair P, Korn S, Ohta K, Lommatzsch M, Ferguson GT, Busse WW, Barker P, Sproule S, Gilmartin G, Werkström V, Aurivillius M, Goldman M; CALIMA study investigators. FitzGerald JM, et al. Among authors: lommatzsch m. Lancet. 2016 Oct 29;388(10056):2128-2141. doi: 10.1016/S0140-6736(16)31322-8. Epub 2016 Sep 5. Lancet. 2016. PMID: 27609406 Clinical Trial.
[Essential diagnostic elements in asthma].
Lommatzsch M. Lommatzsch M. MMW Fortschr Med. 2023 Jun;165(11):36-39. doi: 10.1007/s15006-023-2646-0. MMW Fortschr Med. 2023. PMID: 37258836 Review. German. No abstract available.
Postpartum venous thromboembolism.
Stoll P, Virchow JC, Lommatzsch M. Stoll P, et al. Among authors: lommatzsch m. N Engl J Med. 2009 Apr 9;360(15):1574. doi: 10.1056/NEJMc090080. N Engl J Med. 2009. PMID: 19357419 No abstract available.
113 results